Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 115 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109,469 | -19.7% | 20,086 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $136,384 | +35.5% | 20,086 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $100,631 | +56.3% | 20,086 | +52.3% | 0.00% | 0.0% |
| Q4 2022 | $64,372 | -78.4% | 13,191 | -36.2% | 0.00% | -66.7% |
| Q3 2022 | $298,249 | -4.7% | 20,683 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $312,934 | +27.4% | 20,683 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $245,714 | +13.0% | 20,683 | +54.2% | 0.00% | 0.0% |
| Q4 2021 | $217,457 | -43.2% | 13,415 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $382,864 | -15.6% | 13,415 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $453,427 | +11.8% | 13,415 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $405,670 | -38.9% | 13,415 | 0.0% | 0.00% | -42.9% |
| Q4 2020 | $664,177 | +29.0% | 13,415 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $515,002 | -11.1% | 13,415 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $579,528 | +120.5% | 13,415 | +33.2% | 0.01% | +75.0% |
| Q1 2020 | $262,853 | -16.5% | 10,071 | 0.0% | 0.00% | +33.3% |
| Q4 2019 | $314,719 | +19.9% | 10,071 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $262,450 | – | 10,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
| Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
| MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
| Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
| Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
| Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
| Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
| ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
| Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
| Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |